PCA
NSPR icon

Pallas Capital Advisors’s InspireMD NSPR Stock Holding History

Pallas Capital Advisors’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.2K Buy
13,000
+2,000
+18% +$3.41K ﹤0.01% 851
2025
Q4 		$19.6K Hold
11,000
– – ﹤0.01% 880
2025
Q3 		$26.5K Buy
+11,000
New +$26.7K ﹤0.01% 864

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Pallas Capital Advisors's NSPR Position: Q1 2026 in Review

Pallas Capital Advisors increased its InspireMD (NSPR) stake by 18% in Q1 2026, buying an estimated $3.41K and bringing the position to 13,000 shares worth $21.2K. The position accounts for ﹤0.01% of the portfolio, ranked #851.

Pallas Capital Advisors first reported a position in NSPR in Q3 2025 and has held it in 3 quarters since. The position peaked at $26.5K in Q3 2025. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

  • Pallas Capital Advisors held 13,000 shares of InspireMD worth $21.2K as of Q1 2026.
  • Pallas Capital Advisors bought 2,000 InspireMD shares in Q1 2026, an estimated $3.41K.
  • InspireMD made up ﹤0.01% of Pallas Capital Advisors's portfolio in Q1 2026, its #851 holding.
  • Pallas Capital Advisors first reported a position in InspireMD in Q3 2025 and has held it in 3 quarters since.
  • Pallas Capital Advisors's InspireMD position peaked at $26.5K in Q3 2025.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.